Subject Diabetic
Item
of diabetic subjects:
boolean
C0681850 (UMLS CUI [1,1])
C0241863 (UMLS CUI [1,2])
Diabetes Mellitus, Non-Insulin-Dependent
Item
type 2 diabetes
boolean
C0011860 (UMLS CUI [1])
Age
Item
age: 30-65 years
boolean
C0001779 (UMLS CUI [1])
Body mass index
Item
bmi: 27-35
boolean
C1305855 (UMLS CUI [1])
Subject Diabetic
Item
of nondiabetic subjects:
boolean
C0681850 (UMLS CUI [1,1])
C0241863 (UMLS CUI [1,2])
Age
Item
age: 30-65 years
boolean
C0001779 (UMLS CUI [1])
Body mass index
Item
bmi: 27-35
boolean
C1305855 (UMLS CUI [1])
Subject Diabetic
Item
of diabetic subjects:
boolean
C0681850 (UMLS CUI [1,1])
C0241863 (UMLS CUI [1,2])
Pharmaceutical Preparations Affecting glucose metabolism | Pharmaceutical Preparations Affecting Gene Expression Adipose tissue | Pharmaceutical Preparations Affecting Gene Expression skeletal muscle
Item
medication, which have any influence on glucose metabolism and gene expression in adipose tissue and skeletal muscle at the time of sampling of biopsies.
boolean
C0013227 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0596620 (UMLS CUI [1,3])
C0013227 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C0017262 (UMLS CUI [2,3])
C0001527 (UMLS CUI [2,4])
C0013227 (UMLS CUI [3,1])
C0392760 (UMLS CUI [3,2])
C0017262 (UMLS CUI [3,3])
C1280260 (UMLS CUI [3,4])
Liver disease | Heart Disease | Vascular Diseases | Endocrine System Disease
Item
disease in liver, heart, vessels or endocrine organs
boolean
C0023895 (UMLS CUI [1])
C0018799 (UMLS CUI [2])
C0042373 (UMLS CUI [3])
C0014130 (UMLS CUI [4])
Subject Diabetic
Item
of nondiabetic subjects:
boolean
C0681850 (UMLS CUI [1,1])
C0241863 (UMLS CUI [1,2])
Diabetes Mellitus, Non-Insulin-Dependent
Item
type 2 diabetes
boolean
C0011860 (UMLS CUI [1])
Non-Insulin-Dependent Diabetes Mellitus Relative
Item
relatives with type 2 diabetes
boolean
C0011860 (UMLS CUI [1,1])
C0080103 (UMLS CUI [1,2])
Hyperglycemia
Item
hyperglycemia
boolean
C0020456 (UMLS CUI [1])
Pharmaceutical Preparations Affecting glucose metabolism | Pharmaceutical Preparations Affecting Gene Expression Adipose tissue | Pharmaceutical Preparations Affecting Gene Expression skeletal muscle
Item
medication, which have any influence on glucose metabolism and gene expression in adipose tissue and skeletal muscle at the time of sampling of biopsies.
boolean
C0013227 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0596620 (UMLS CUI [1,3])
C0013227 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C0017262 (UMLS CUI [2,3])
C0001527 (UMLS CUI [2,4])
C0013227 (UMLS CUI [3,1])
C0392760 (UMLS CUI [3,2])
C0017262 (UMLS CUI [3,3])
C1280260 (UMLS CUI [3,4])
Liver disease | Heart Disease | Vascular Diseases | Endocrine System Disease
Item
disease in liver, heart, vessels or endocrine organs
boolean
C0023895 (UMLS CUI [1])
C0018799 (UMLS CUI [2])
C0042373 (UMLS CUI [3])
C0014130 (UMLS CUI [4])